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Abstract: Eukaryotic cells have evolved a number of survival tactics and quality control pathways that are able to 
counter intrinsic error-prone mechanisms and allow for maintenance of cellular homeostasis in the face of exter-
nal stresses. This review will discuss the role of two cellular eukaryotic processes that are vital for maintenance of 
cellular homeostasis – 1) the nonsense-mediated mRNA decay (NMD) pathway and 2) the transient formation of 
stress granules (SG) – and explore the current literature on their roles in antiviral defence. Within the NCCR RNA 
& Disease, the laboratories of Proffs. O. Mühlemann and Volker Thiel teamed up to unravel the roles of NMD and 
SGs, and their interconnections in defending cells from alphavirus and coronavirus infections.
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1. The Role of NMD in Post-transcriptional Gene 
Regulation and mRNA Quality Control
Nonsense-mediated mRNA decay (NMD) is best known for 
its role in mRNA quality control, where it rids the cytoplasm of 
transcripts with premature stop codons (PTCs) that could oth-
erwise result in the translation of non-functional or potentially 
harmful, truncated proteins.[1,2] Such PTCs could have arisen 
through nonsense or frameshift mutations in DNA, errors in tran-
scription, or errors in splicing.[2] PTCs could, however, also arise 
from alternative splicing events that produce multiple mRNA 
isoforms from a single gene. In many genes coding for splicing 
factors, these alternatively spliced PTC-containing transcripts are 
targeted by NMD, thereby linking the two processes in a mech-
anism referred to as alternative splicing-NMD (AS-NMD). AS-
NMD is physiologically relevant as the regulation of one splice 
variant versus another can modulate splicing, cell function/iden-
tity (reviewed in ref. [3]). AS-NMD therefore presents a distinct 
example of the role of NMD, not only in quality control, but also 
in post-transcriptional regulation of gene expression. It has be-
come evident that this regulatory role of NMD extends beyond 
targeting of PTC-containing transcripts, with genome-wide data 
revealing that ~10% of endogenous mRNAs in mammalian cells 
are targeted by NMD.[2,4,5] Since the presence of a PTC does not 
account for all NMD-sensitive transcripts, the features/context 
that renders a mRNA a target of NMD remains an open ques-
tion. Nevertheless, some features, including 3'UTR introns, long 
3'UTRs, and upstream open reading frames (uORFs) have been 
shown to be enriched in endogenous NMD targets.[5]
It has long been established that NMD depends on translation, 
with a number of translation inhibitors (with different modes of 
action) all abrogating NMD.[6,7] More specifically, evidence sug-
gests that NMD is tightly coupled to translation termination; and 
the current NMD model posits that aberrant or kinetically slow 
translation termination is the NMD triggering event.[7–11] It should 
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that the replication of the full length genome masked the ini-
tial NMD-targeting event. [20] Infection of N. benthamiana with 
Turnip Crinkle Virus (TCV), another +ssRNA virus that differs 
from PVX in that it lacks a 5'-cap and 3'-poly(A) tail, showed 
accumulation of full length gRNA as well as two sgRNAs (all 
with long 3'UTRs) in NMD-deficient compared to NMD-active 
conditions.[20]
Balistreri and colleagues found that depletion of the NMD 
factors, UPF1, SMG5 and SMG7 resulted in increased replica-
tion of the +ssRNA alphavirus, Semliki Forest Virus (SFV). This 
study was the first to identify additional NMD factors involved 
in viral restriction, thereby providing stronger evidence for the 
role of the NMD pathway itself in viral defence, as opposed to an 
NMD-independent role of UPF1. The increase in SFV replication 
in UPF1-depleted cells was strikingly pronounced when a replica-
tion-deficient SFV mutant was used.[21] This indicated that NMD 
was likely involved in hindering translation of early viral repli-
case proteins, possibly by degrading the incoming SFV genome. 
Indeed, DNA-branched fluorescence in situ hybridisation (FISH) 
studies performed 30 minutes post infection revealed that deple-
tion of UPF1 increased the half-life of the SFV gRNA. [21] The 
SFV genome is bi-cistronic, therefore translation of the first ORF 
mimics translation of an mRNA with a long 3'UTR. Surprisingly, 
an increase in viral replication in UPF1-depleted cells was also 
observed in SFV VLPs in which most of the 3'UTR was delet-
ed (∆3'UTR SFV).[21] It should be noted, however, that half-life 
measurements of the ∆3'UTR SFV gRNA under these conditions 
were not performed.
Research into the role of NMD in antiviral defence is gain-
ing traction, with studies in the current year adding both Mouse 
Hepatitis Virus (MHV) (a murine coronavirus) and Zika virus 
(ZIKV) to the growing list of +ssRNA viruses shown to be re-
stricted by NMD.[22,23] Virus replication and virus titres of MHV 
were significantly increased in cells depleted of the NMD factors, 
UPF1, UPF2, SMG5 and SMG6.[22] Additionally, half-life meas-
urements of MHV gRNA and an MHV sg-like RNA reporter re-
vealed that NMD-depletion by UPF1 and UPF2 siRNAs increased 
viral RNA stability. This indicated that both the MHV gRNA and 
one of the sgRNAs (with a long 3'UTR) were both targeted by 
NMD.[22] Similarly, depletion of UPF1 resulted in increased RNA 
levels and viral titres of the highly pathogenic ZIKV.[23]
The replication cycles of all the NMD-restricted viruses dis-
cussed above occur exclusively in the cytoplasm, with the ge-
nomes never being exposed to the host cell nuclear machinery. 
This is an interesting aspect, as it reflects the first clear example of 
splicing-independent and, by inference, EJC-independent NMD 
in mammalian cells – a model that was proposed a while ago[2,17] 
but that has not yet been fully embraced by the NMD community.
3. Inherent Viral Features Confer NMD Resistance
For successful infection, viruses need to overcome the NMD 
machinery of their hosts. Turnip Mosaic Virus (TMV), a +ssRNA 
virus that encodes all proteins on a single ORF, was shown to be 
resistant to NMD.[20] Viruses encoding single ORFs present no 
internal TCs and shorter 3'UTRs and it is therefore appealing to 
hypothesise that other viruses of this nature are inherently NMD 
resistant, although this did not hold true for ZIKV.[23] Other exam-
ples of inherent viral features that confer NMD resistance have also 
been described.[24–27] For example, the retrovirus, Rous Sarcoma 
Virus (RSV), escapes NMD through a 400 nt RNA-stability ele-
ment (RSE) encoded in its genome.[28,29] The RSE was found to be 
a binding site for polypyrimidine tract binding protein 1 (PTBP1), 
which prevented UPF1 recruitment to otherwise NMD-sensitive 
reporter transcripts, thereby rendering them NMD-insensitive. [24] 
It has been reported that NMD can be inhibited by inducing trans-
lational readthrough events.[26,30] Many multicistronic viruses 
depend on readthrough-enhancing elements in their genomes in 
be noted that poly(A)-binding protein (PABP) has been character-
ised to suppress NMD when in close proximity to the termination 
codon (TC). Accordingly, if PABP is distant from the TC (as is the 
case for mRNAs with long 3'UTRs), NMD can ensue.[12–14] NMD 
activation and the ultimate degradation of target mRNAs depends 
on the dynamic assembly of a protein complex of which several 
evolutionarily conserved core NMD factors have been described.[7] 
Interestingly, crosslinking immunoprecipitation (CLIP)-seq stud-
ies revealed that the central NMD factor, Up-frameshift 1 (UPF1), 
appears to bind RNA non-specifically, though significant enrich-
ment of UPF1 bound to 3'UTRs was also observed.[15] A popu-
lar hypothesis postulates that when translation fails to terminate 
efficiently/correctly, it allows time for RNA-bound UPF1 to be 
activated by subsequent recruitment of downstream NMD factors. 
The NMD factors, UPF2 and/or UPF3 that are either free in the cy-
toplasm or positioned nearby on an exon junction complex (EJC), 
bind UPF1, thereby triggering a conformational change that allows 
UPF1 to be phosphorylated by the kinase SMG1. Phosphorylation 
of UPF1 allows for the subsequent recruitment of the NMD-
specific degradation machinery (see Fig. 1 below). Namely, the 
SMG6 endonuclease which binds and degrades mRNA through 
its intrinsic ribonuclease activity, as well as the SMG5/SMG7 
heterodimer which stimulates exonucleolytic mRNA degradation 
through recruitment of deadenylases and decapping enzymes.[7,16] 
It should also be noted that the presence of an EJC downstream of 
a termination codon (as would be the case for mRNAs encoding an 
intron in the 3'UTR) has been reported to enhance NMD; although 
is not required in order for NMD to ensue.[2,17]
2. Viral Genomes are Targeted by NMD
Viruses depend on their hosts in order to proliferate. Positive-
sense single stranded RNA (+ssRNA) viruses are unique in that 
they depend on the host cell translation machinery immediately 
after entry into the cell so that their replicase proteins can be trans-
lated. Viruses have evolved to maximise their coding capacity 
while retaining relatively short genomes.[18] For +ssRNA viruses, 
all proteins need to be encoded in a single strand with limited 
space. This means their genomes are often comprised of multi-
ple ORFs, hence encompassing multiple TCs on a single RNA. 
During translation of the viral genomic RNA (gRNA), the internal 
TCs could be recognised as PTCs by the host NMD machinery. 
In addition, translation of the first ORF of a bi- or multi-cistronic 
+ssRNA genome could mimic translation of an mRNA with a long 
3'UTR, which could also trigger NMD.[3,18] Indeed, the genomes 
of several +ssRNA viruses have now been identified as NMD 
targets,[19–23] prompting the view that NMD could play a role in 
innate antiviral defence. In 2014, Wernet and colleagues[19] were 
able to increase titres of infectious virus-like particles (VLPs) of 
the alphavirus, Sindbis virus (SINV), produced in Drosophila, by 
co-expressing a dominant negative UPF1 mutant that abrogated 
NMD. Following that report, two back-to-back research articles in 
the same year reported the restriction of three additional +ssRNA 
viruses by NMD.[20,21]
Garcia and colleagues showed increased Potato Virus X 
(PVX) infection in NMD-deficient plants (N. benthamiana) com-
pared to NMD-active plants. Additionally, northern blot analyses 
showed that two subgenomic (sg) RNAs of PVX (both with long 
3'UTRs) had increased abundance in the NMD-deficient condi-
tions compared to NMD-active conditions, whereas the 3' proxi-
mal sgRNA which did not have a long 3'UTR showed no changes 
in abundance. From this, and an additional experiment whereby 
they expressed a mutant of one of the sgRNAs that lacked the 
3'UTR in NMD-deficient versus NMD-active conditions, the 
authors concluded that restriction of the sgRNAs by NMD was 
dependent on the presence of a long 3'UTR.[20] Interestingly, the 
full length gRNA of PVX was only restricted by NMD in con-
ditions where virus replication was impaired. It became evident 
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radation of UPF1 was occurring in the nucleus of ZIKV capsid 
expressing cells.[23] Taken together, the authors suggested that 
ZIKV capsid specifically targets nuclear UPF1 for degradation 
by the proteasome.[23] Since ZIKV infection during pregnancy is 
well established to cause microcephaly[33] and genetic mutations 
that impair NMD have been described to be associated with mi-
crocephaly;[23,34–36] the link between ZIKV infection and NMD 
suppression could shed light on the molecular mechanisms by 
which ZIKV causes disease. Taken together, the interplay be-
tween the host NMD pathway and viruses can be viewed as a tug 
of war between the virus establishing infection and the host cell 
contending to rid the cell of the viral stress with the ultimate goal 
of restoring homeostasis.
5. The Integrated Stress Response and Stress 
Granules
Like NMD, the integrated stress response (ISR) is a pathway 
in eukaryotic cells that is tightly linked to translational regulation. 
The ISR is tasked with the sensing of a multitude of extrinsic and 
intrinsic stresses and the subsequent reprogramming of transla-
tion in order to ultimately restore homeostasis.[37,38] ISR responds 
to a variety of stressors such as hypoxia, amino acid deprivation, 
accumulation of unfolded proteins in the endoplasmic reticulum 
(ER), and viral infection.[37,39] The hallmark feature of an activat-
ed ISR is the phosphorylation of the α-subunit of the eukaryotic 
translation initiation factor 2 (eIF2α).[37,40] The result of this phos-
phorylation causes a decrease in cap-dependent translation initi-
ation on the majority of mRNAs, while simultaneously activat-
ing translation of select mRNAs. These stress-activated mRNAs 
encode for proteins tasked with restoring homeostasis and re-
lieving the cell of the stress conditions.[38,41,42] Prolonged stress, 
however, will lead to apoptosis if it overwhelms the cells adaptive 
capability. Dephosphorylation of eIF2α, in turn, acts as a stopping 
signal to the ISR response.[37,38]
In mammalian cells, eIF2α can be phosphorylated by four 
distinct kinases, dependent on the kind of stress: Heme regulated 
eIF2α kinase (HRI) is activated in response to oxidative stress 
and heme deprivation,[43] while general control non-depressible-2 
(GCN2) is activated upon amino acid deprivation and UV radi-
ation.[44] Protein kinase RNA-dependent (PKR) activates ISR in 
the presence of viral infections by sensing double-stranded (ds) 
RNA[45] and PKR-like ER kinase (PERK) is activated in response 
to misfolded proteins in the ER or by hypoxia.[46] In its phos-
phorylated form, eIF2α prevents the regeneration of the ternary 
complex (eIF2-GTP-tRNA
Met
) that is required for translation in-
itiation.[38,47,48] Instead, translation initiation is stopped after for-
mation of the 48S pre-initiation complex and the large ribosomal 
subunit cannot be recruited to start elongation.[49] The result of 
that mechanism is an accumulation of stalled 48S mRNPs, which 
are then concentrated into cytoplasmic foci called stress granules 
(SG, Fig. 1).[45]
SGs are dynamic structures that are in constant equilibrium 
with translating polysomes and thought to triage mRNAs during 
stress conditions.[47,50] SGs contain stalled mRNA molecules, 40S 
ribosomal subunits, several translation initiation factors and RNA 
binding proteins, and they also appear to be hubs for a variety of 
signalling cascades.[48,50] While there are other pathways that lead 
to SG formation, such as inhibition of the RNA helicase eIF4A, 
eIF2α phosphorylation is the best studied pathway that leads to 
canonical stress granules.[51] Increasing evidence suggests that 
SG formation is a multi-step process.[52] First, a variety of RNA 
binding proteins (RBP), including T-cell restricted intracellular 
antigen 1 (TIA-1), TIA-1-related protein (TIAR), and RasGAP 
SH3-domain binding protein 1 (G3BP1), bind to non-translating 
48S mRNPs and form dense, stable core aggregates.[48,52] In a next 
step, intrinsically disordered regions (IDR), which are present in 
many RNA binding proteins (RBP) targeted to SGs, promote 
order to allow regulated translation of downstream ORFs. These 
inherent readthrough elements could therefore provide protection 
from NMD. Indeed, the RNA pseudoknot readthrough-enhanc-
ing element of the retrovirus, Moloney Murine Leukemia Virus 
(MoMLV), was able to rescue NMD-sensitive reporter transcripts 
from degradation by NMD.[25,26] More recently, a ribosomal read-
through element identified from the +ssRNA virus, TCV; as well 
as a –1 frameshift-inducing element in the +ssRNA virus, Pea 
enation mosaic virus (PEMV2) were also shown to rescue NMD-
sensitive reporters when placed in a position/context that promot-
ed readthrough.[27]
In addition, in 2018 May and colleagues identified an un-
structured region (USR) in the 5' portion of the TCV 3'UTR that 
also conferred NMD resistance.[27] The authors went on to show 
that the 3'UTRs of other carmoviruses, including Cardamine 
chlorotic fleck virus (CCFV), Carnation mottle virus (CarMV) 
and Calibrachoa mottle virus (CbMV) could also rescue NMD-
sensitive reporters, with TCV and CCFV 3'UTRs even maintain-
ing NMD-resistance when placed downstream of a reporter with 
a longer 3'UTR.[27] Interestingly, introduction of mutations that 
introduced stable hairpins in the USR of TCV abrogated NMD-
resistance.[27] The authors noted that endogenous transcripts with 
long 3'UTRs >1400nt that escape NMD, have less structured 
regions 75 nt downstream of the TC compared to endogenous 
NMD targets with long 3'UTRs.[27] Since the context that renders 
a transcript an NMD target is still an open question in the field, 
this finding is significant as the presence of an unstructured region 
immediately downstream of a TC could explain why many en-
dogenous mRNAs are protected from NMD despite having long 
3'UTRs.[27]
4. Viruses Actively Inhibit NMD
In addition to specific features in viral genomes conferring 
resistance to NMD in cis, reports demonstrating global NMD 
inhibition by viral infection have also been described.[22,23,31,32] 
Human T-lymphotropic Virus Type 1 (HTLV-1) inhibits NMD 
through direct binding of its TAX protein to UPF1, thereby either 
preventing UPF1 association to RNA or disrupting UPF1 heli-
case activity.[32] A number of +ssRNA viruses that inhibit global 
NMD, including Hepatitis C Virus (HCV), MHV and ZIKV have 
also come to light.[22,23,31] Infection with HCV was shown to in-
crease levels of endogenous NMD reporters in hepatoma cells 
and it was postulated that binding of the HCV core protein to 
the EJC factor PYM could be the mechanism by which NMD 
was suppressed. [31] In addition to its genome being a direct target 
of NMD, MHV suppressed NMD at later stages of infection. 
Expression of individual MHV proteins revealed that the nucleo- 
capsid protein was responsible for the NMD-inhibitory pheno-
type.[22] Since viruses are well known to inhibit global translation 
and NMD is dependent on translation, it could be hypothesised 
that viruses suppress NMD through suppression of translation. 
Wada and colleagues showed, however, that NMD targets accu-
mulated 2 hours prior to observation of global translation inhibi-
tion. In addition, it was shown using luciferase reporters that ex-
pression of the MHV nucleocapsid did not reduce translation.[22] 
Although no mechanistic insight was given, the study pointed 
towards an active role of NMD inhibition by the MHV nucleo- 
capsid.[22] Infection of cells with the highly disease-relevant 
ZIKV also caused NMD inhibition. [23] Using affinity purification 
coupled with mass spectrometry, the authors identified interac-
tions of ZIKV capsid protein (from two different ZIKV strains) 
with many NMD factor components, including UPF1, UPF3B 
and a number of EJC components. [23] Strikingly, ZIKV capsid 
expression resulted in significant downregulation of UPF1 pro-
tein, while UPF1 transcript levels remained stable. Interestingly, 
the authors demonstrated that the nuclear UPF1 fraction was 
specifically downregulated and that proteasome-mediated deg-
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internal ribosomal entry sites (IRES), which utilize cap-independ-
ent translation that is less sensitive to ISR activation.[48,64] In cases 
where a virus loses its ability to control SG formation, for example 
because of a mutation in a viral protein, it was shown that viral 
propagation can be significantly reduced.[65,66] Notably, several 
viruses have been reported to block SG formation downstream 
of translation inhibition even if they use IRES-based translation 
initiation.[48] The finding that the presence of SGs is not required 
for ISR mediated translation inhibition suggests that SGs are more 
than a side effect of translation inhibition and may possess anti-
viral function. 
7. Stress Granules and Antiviral Responses
The ISR is only one mode of action against viruses and the 
cell has additional lines of defence including the innate immune 
response. The innate immune response is activated upon recog-
nition of pathogen-associated molecular patterns (PAMP), which 
in the case of viruses most often consist of their RNA or DNA. 
The sensors that bind these PAMPs are called pattern recognition 
receptors (PRR). In the case of virus recognition, PRRs include 
melanoma differentiation-associated gene 5 (MDA5), retino-
ic acid-inducible gene I (RIG-I) and laboratory of genetics and 
physiology 2 (LGP2), which are collectively called RIG-I-like re-
ceptors (RLR). If RLRs sense a viral infection in the cytoplasm, 
a signaling cascade is initiated that leads to the activation of tran-
scription factors, interferon regulatory factor (IRF) 3, IRF7 and 
nuclear factor-κB (NFκB). This, in turn leads to the production 
of the type 1 interferon (IFN) and other cytokines that initiate an 
extensive antiviral immune response via the expression of IFN 
stimulated genes (ISG).[67–69]
liquid–liquid phase separation to form a liquid-like layer around 
the stable cores.[48,52–54] Held together by an interwoven network 
of weak interactions between proteins and RNA, these SGs fuse 
with one another and form huge compartments containing multi-
ple cores.[48,52,55]
6. Stress Granules and Viruses
Since all viruses depend on the cellular translation machinery 
for their replication, it is not surprising that eukaryotic cells have 
developed means to restrict protein synthesis in infected cells. One 
of the key components for this antiviral translational reprogram-
ming is the aforementioned eIF2α kinase PKR. In the presence of 
dsRNA, which constitutes an important intermediary for RNA vi-
ruses, PKR dimerizes and phosphorylates itself. Besides dsRNA, 
other viral RNA motifs, such as 5'-triphosphate RNA.[45,48] have 
been described to activate PKR as well. In addition, PKR is not 
the only eIF2α kinase to play a role in antiviral defence, as both 
GCN2[56] and PERK[57] have been implicated in activating the ISR 
in response to viruses. Once activated, PKR phosphorylates eIF2α 
and triggers the ISR, which leads to the formation of SGs. SGs are 
intrinsically linked to the ISR and to translation, and many virus-
es have developed diverse countermeasures against these cellular 
defences. For example, Influenza A directly blocks activation of 
PKR and thus prevents the activation of the ISR.[58,59] Other vi-
ruses, such as Poliovirus, specifically cleave essential SG proteins 
like G3BP1.[60,61] An additional viral strategy is the sequestration 
of SG proteins, as shown for Semliki Forest Virus.[60,62] Yet other 
viruses, like MHV, just seem to tolerate SG formation and rep-
licate normally in their presence.[58,63] A strategy to circumvent 
the phospho-eIF2α-induced translation suppression is the use of 
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Fig. 1. The NMD pathway is dependent on translation and translation is stalled after SG formation. Critical host proteins that impact NMD, SG for-
mation, and interferon responses are depicted. In order for a transcript to be degraded by NMD, UPF1 binds the transcript and is phosphorylated by 
the NMD factor kinase, SMG1. Phosphorylated UPF1 recruits the NMD degradation machinery. Namely, the SMG6 endonuclease and/or the SMG5/
SMG7 heterodimer, which stimulates degradation by recruitment of deadenylases and decapping enzymes. Various genomic and subgenomic RNAs 
of +ssRNA viruses have been described to be targeted by the NMD machinery, prompting the view that NMD could play a role in innate antiviral 
defence. Similarly, SGs have been proposed to play a role in innate antiviral defence mechanisms. Activation of eIF2α kinases can lead to SG forma-
tion through phosphorylation of eIF2α. The presence of canonical SG markers (TIA1, TIAR, and G3BP1), components of the NMD pathway (UPF1, 
SMG1), dsRNA-specific PRRs (Rig-I, Mda5, PKR), and ISGs with antiviral activity (OAS, RNase L), suggests a link of these diverse cellular pathways 
in the context of antiviral host responses.
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In recent years, several reports have linked SGs to antiviral 
immune pathways. It was shown that RLRs but also PKR are re-
cruited to SGs in the case of eIF2α phosphorylation (Fig. 1).[70,71] 
In the case of a mutant Influenza A virus (IAV), SGs were formed 
and colocalized with dsRNA sensors RIG-I, MDA5 and PKR, and 
SG formation was necessary for efficient type 1 IFN induction. [70] 
Another report showed that a mutant Mengovirus induced SGs 
that recruited MDA5.[71] In contrast to the report on IVA, however, 
SG formation was uncoupled to IFN expression in Mengovirus 
infection.[66,71] In addition, several important cofactors to the RLR 
mediated IFN response, such as tripartite motif-containing pro-
tein 25 (TRIM25)[72] or tumor necrosis factor receptor-associated 
factor 2 (TRAF2),[73] were also found to localize to SGs. [48] The 
finding of several viral RNA sensors and components of the corre-
sponding signaling pathways recruited to SGs led to the hypothesis 
that SGs might function as signaling platforms for the innate im-
mune system that may even be necessary for their activation.[48,70] 
However, the extent to which IFN expression and PKR activa-
tion are connected is controversial. Some studies show that cells 
deficient for PKR have an impaired IFN response, while others 
found that PKR activation has no influence on IFN expression.[66] 
Differences in cell types and viruses might account for this dis-
crepancy, but more evidence is needed to solve this issue. Several 
ISG-encoded proteins were also found to colocalize with SGs in 
the case of virus infection. PKR is the ISG with the best docu-
mented link to SGs. While already expressed under normal condi-
tions, PKR activity is enhanced upon IFN induction. Additionally, 
it has been shown that inactive PKR can be activated independent-
ly of dsRNA by interacting with the SG components G3BP1 and 
Caprin1.[74] 2',5'-oligoadenylate synthetases (OAS) are another 
group of ISGs that were also found in SGs together with their 
effector protein RNase L.[70] Upon binding of dsRNA, the OAS 
proteins generate 2',5'-oligoadenylate, which activates RNase L. 
Once activated, RNase L degrades viral and cellular RNA.[69] All 
these findings suggest that at least some parts of the antiviral im-
mune response is linked to SGs. However, their specific role in 
that context is only partially understood and needs further study.
8. A Connection between NMD and SGs in Defending 
Cells against Viruses?
Interestingly, core components of the NMD pathway, UPF1 
and SMG1, have been shown to localize to SGs induced by ox-
idative stress.[75] It would be interesting to know whether NMD 
factors also localize to SGs that are induced by virus infections 
and whether a link exists between innate immune sensing, SGs, 
and NMD in the context of host cell responses to virus infections. 
Using SFV and coronavirus as models, the collaborative research 
project between the laboratories of Proffs. Mühlemann and Thiel 
is trying to answer exactly these questions with the goal of better 
understanding the molecular connections between SGs, NMD and 
their roles in protecting cells from virus infections.
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